Document Detail


The fibrinolytic system is not impaired in older men with hypertension.
MedLine Citation:
PMID:  8621196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The fibrinolytic system is thought to be impaired in older hypertensive adults, thus contributing to the elevated risk of atherothrombosis, stroke, and acute myocardial infarction in this population. However, studies that have examined the fibrinolytic system in hypertensive individuals have failed to control for the confounding effects of other metabolic risk factors, making it difficult for one to determine the independent effect of hypertension on the fibrinolytic system. The purpose of the present study was to test the hypothesis that the fibrinolytic system is not impaired in older sedentary hypertensive men when the confounding effects of cardiovascular disease, diabetes, and dyslipidemia are controlled. Plasma concentrations of tissue-type plasminogen activator antigen and activity as well as plasminogen activator inhibitor-1 antigen and activity were measured under resting conditions in 12 hypertensive (69.4 +/- 1.4 years) and 11 normotensive 65.2 +/- 1.3 years) older men. The hypertensive and normotensive subjects had similar anthropometric and metabolic characteristics. There were no significant differences between the hypertensive and normotensive men in tissue-type plasminogen antigen (7.3 +/- 0.5 versus 6.1 +/- 0.6 ng/mL) and activity (1.8 +/- 0.3 versus 1.7 +/- 0.2 IU/mL) or plasminogen activator inhibitor-1 antigen (14.1 +/- 2.3 versus 10.8 +/- 2.2 ng/mL) and activity (17.4 +/- 1.2 versus 17.5 +/- 1.8 arbitrary units [AU]/mL) levels. In addition, the molar concentration ratio of active tissue type plasminogen activator to active plasminogen activator inhibitor-1 did not differ between the hypertensive (1:9.7 +/- 2.3) mmol/L) and normotensive (1:10.5 +/- 2.2 mmol/L) subjects, indicative of no impairment in fibrinolytic potential in either group. These results support the hypothesis that hypertension does not directly result in impaired fibrinolytic function in older adults. Furthermore, our findings suggest that abnormalities in fibrinolytic function in older hypertensive men are likely due to the primary effects of other metabolic disorders that usually accompany hypertension, such as hyperinsulinemia and dyslipidemia.
Authors:
C A DeSouza; D R Dengel; M A Rogers; K Cox; R F Macko
Related Documents :
7895356 - Aging and endothelial function in normotensive subjects and patients with essential hyp...
21801596 - Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothe...
22234736 - Effects of different tidal volumes in pulmonary and extrapulmonary lung injury with or ...
22216396 - Early sequential changes in bladder function after partial bladder outlet obstruction i...
6716636 - Hemodynamic effects of nitroprusside on cardiovascular system.
23498356 - The effects of different shoes on plantar forces in irish dance.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Hypertension     Volume:  27     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-06-14     Completed Date:  1996-06-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1053-8     Citation Subset:  IM    
Affiliation:
Department of Kinesiology, University of Maryland, College Park, USA. desouzac@stripe
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aging / blood,  physiology*
Antigens / analysis
Cross-Sectional Studies
Fibrinolysis / physiology*
Humans
Hypertension / blood,  immunology,  physiopathology*
Male
Middle Aged
Plasminogen Activator Inhibitor 1 / blood,  immunology
Sex Factors
Tissue Plasminogen Activator / blood,  immunology
Grant Support
ID/Acronym/Agency:
T-32 AG00291/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Antigens; 0/Plasminogen Activator Inhibitor 1; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a m...
Next Document:  Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged ...